News | March 13, 2024
Nirma acquires majority stake in Glenmark Life Sciences
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
Nectar Lifesciences has clarified that the company has no relation/connection/ association or link of any nature with the Nectar Herbs and Drugs
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
_256_384.jpg)
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
VeerHealth Care will be raising Rs. 8 crores through bank borrowings
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Subscribe To Our Newsletter & Stay Updated
